Login / Signup

Use of non-vitamin K antagonist oral anticoagulants in Colombia: A descriptive study using a national administrative healthcare database.

Jorge Enrique Machado-AlbaAndrés Gaviria-MendozaManuel E Machado-DuqueCarlos Tovar-YepesAna RuigómezLuis Alberto García-Rodríguez
Published in: Pharmacoepidemiology and drug safety (2020)
During the last decade, the incidence of NOAC use in patients with NVAF affiliated with a private healthcare regime in Colombia has markedly increased. Future studies should evaluate whether the large number of patients with NVAF starting NOAC treatment on a reduced dose are done so appropriately.
Keyphrases
  • oral anticoagulants
  • healthcare
  • atrial fibrillation
  • risk factors
  • quality improvement
  • current status
  • health insurance
  • case control
  • replacement therapy
  • affordable care act